Another investigation assessed the impact of intraoperative and postoperative DEX vs. placebo on NK cell function in patients with uterine cancer, revealing increased interferon-gamma (IFN-γ) levels in the DEX group.5 This evidence concerns the gene IFNG and uterine cancer.